Serveur d'exploration Tocilizumab - Analysis (France)

Index « Teeft.i » - entrée « Baseline »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Basdai < Baseline < Baseline characteristics  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000513 (2013) Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Jean François Ferlet [France] ; Sandrine Jousse-Joulin [France] ; Maria-Antonietta D'Agostino [France] ; Marina Backhaus [Allemagne] ; Jacques Bentin [Belgique] ; Gérard Chalès [France] ; Isabelle Chary-Valckenaere [France] ; Philip Conaghan [Royaume-Uni] ; Richard J. Wakefield [Royaume-Uni] ; Frédéric Etcheparre [France] ; Philippe Gaudin [France] ; Walter Grassi [Italie] ; Désirée Van Der Heijde [Pays-Bas] ; Xavier Mariette [France] ; Esperanza Naredo [Espagne] ; Marcin Szkudlarek [Danemark]The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound
000517 (2013) Philip G. Conaghan [Royaume-Uni] ; Patrick Durez [Belgique] ; Rieke E. Alten [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Lars Klareskog [Suède] ; Anca Irinel Catrina [Suède] ; Julie Dicarlo [États-Unis] ; Corine Gaillez [France] ; Manuela Le Bars [France] ; Xianhuang Zhou [États-Unis] ; Charles Peterfy [États-Unis]Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
000518 (2013) Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
000520 (2013) Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas]Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
000525 (2013) Y. Van Eijk-Hustings [Pays-Bas] ; B. Buss [Allemagne] ; F. Fayet [France] ; A. Moretti [Italie] ; M. Ndosi [Royaume-Uni] ; S. Ryan [Royaume-Uni] ; C. Savel [France] ; M. Scholte-Voshaar [Pays-Bas] ; J. De La Torre-Aboki [Espagne] ; A. Van Tubergen [Pays-Bas]THU0598 Dissemination and Evaluation of the Eular Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis
000526 (2013) B. Fautrel [France] ; J.-M. Joubert ; G. Cukierman ; C. Laurendeau ; J. Gourmelen [France] ; F. FagnaniTHU0512 Rheumatoid Arthritis (RA), Comorbidities and Biological Agents Uptake in France: Analysis of a National Claims Database
000527 (2013) N. Droz ; L. Gilardin ; P. Cacoub [France] ; F. Berenbaum ; D. Wendling ; E. Dernis [France] ; B. Fautrel [France] ; S. Pol ; L. Guillevin ; L. Mouthon ; B. TerrierTHU0427 New Insights into the Presentation and the Management of Hepatitis B Reactivation in Patients with Immune Mediated Inflammatory Diseases
000529 (2013) S. Ozen ; E. Demirkaya [Turquie] ; G. Amaryan [Arménie] ; I. Koné-Paut [France] ; P. Woo [Royaume-Uni] ; Y. Uziel [Israël] ; M. Finetti [Italie] ; P. Quartier [France] ; C. Modesto [Espagne] ; E. Papadopoulou-Alataki [Grèce] ; S. Nielsen [Danemark] ; M. Hofer [Suisse] ; A. Polat [Turquie] ; T. Turker [Turquie] ; A. Insalaco [Italie] ; L. Cantarini [Italie] ; S. M. Al-Mayouf [Arabie saoudite] ; J. Frenkel [Pays-Bas] ; H. Ozdogan [Turquie] ; N. Ruperto [Italie] ; M. Gattorno [Italie]THU0334 Differences in the features of familial mediterranean fever among patients from europe as compared to those from the eastern mediterranean countries
000530 (2013) J. S. Smolen [Autriche] ; A. Kavanaugh [États-Unis] ; D. Van Der Heijde [Pays-Bas] ; S. Florentinus [France] ; S. S. Rathmann [États-Unis] ; H. Kupper [Allemagne] ; E. C. Keystone [Canada]THU0209 Disease Activity and Structural Damage-Related Differences in Functional Disability in Early and Established Rheumatoid Arthritis
000531 (2013) A. Frazier-Mironer [France] ; A. Cantagrel [France] ; B. Combe [France] ; V. Deschamps ; M. Dougados [France] ; R.-M. Flipo ; I. Logeart ; X. Mariette ; T. Schaeverbeke ; J. Sibilia [France] ; X. Le Loët [France]THU0173 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biologic Therapy in Patients with Rheumatoid Arthritis in Daily Practice: The Maintain Study
000532 (2013) I. Castrej N [États-Unis] ; M. Dougados [France] ; B. Combe [France] ; F. Guillemin [France] ; B. Fautrel [France] ; T. Pincus [États-Unis]THU0165 Predictive Value of Different Remission Criteria for a Good Functional Status Outcome: Results from the Espoir Cohort
000533 (2013) C. Gaujoux-Viala [France] ; L. Gossec [France] ; M. Dougados [France] ; F. Guillemin [France] ; B. Fautrel [France]THU0134 Favorable Outcome, a New Concept for the Evaluation of Health Status in Rheumatoid Arthritis (RA) not so Easy to Achieve: Results from the Espoir Cohort
000534 (2013) Y.-M. Pers [France] ; C. Fortunet ; E. Constant ; J. Lambert [France] ; A. Mazouyes [France] ; M. Valnet [France] ; H. Marotte ; P. Gaudin [France] ; D. Wendling [France] ; J.-F. Maillefert ; C. Jorgensen [France]THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD
000535 (2013) S. Godot [France] ; J. E. Gottenberg [France] ; S. Paternotte ; I. Pane [France] ; B. Combe [France] ; J. Sibilia [France] ; R.-M. Flipo ; T. Schaeverbeke ; P. Ravaud [France] ; E. Toussirot ; F. Berenbaum [France] ; X. Mariette [France] ; D. Wendling ; J. Sellam [France]THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry
000537 (2013) M. Dougados [France] ; K. Kissel [Suisse] ; P. G. Conaghan [Royaume-Uni] ; E. Martin-Mola [Espagne] ; G. Schett [Allemagne] ; H. Amital [Israël] ; R. M. Xavier [Brésil] ; O. Troum [États-Unis] ; C. Bernasconi [Suisse] ; T. W. J. Huizinga [Pays-Bas]THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study
000538 (2013) L. Gossec [France] ; S. Rouanet ; G. Steinberg ; B. Combe [France]THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life
000542 (2013) D. Kingsbury [États-Unis] ; P. Quartier [France] ; V. Arora [États-Unis] ; J. Kalabic [Allemagne] ; H. Kupper [Allemagne] ; N. Mozaffarian [États-Unis]SAT0436 Safety and Effectiveness of Adalimumab in Children with Polyarticular Juvenile Idiopathic Arthritis Aged 2 To <4 Years or ≥4 Years Weighing <15 KG
000543 (2013) A. Saraux ; S. Rouanet ; R.-M. Flipo ; J.-C. Poncet ; P. Fardellone ; C. Contré [France] ; A. Cantagrel [France]SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study
000545 (2013) J. Mélet ; D. Mulleman ; P. Goupille ; B. Ribourtout [France] ; H. Watier [France] ; G. Thibault [France]SAT0102 Rituximab-Induced T-Cell Depletion in Patients with Rheumatoid Arthritis: Association With Clinical Response
000547 (2013) T. Krams ; A. Ruyssen-Wtrand [France] ; D. Nigon ; B. Fautrel ; F. Berenbaum [France] ; A. Cantagrel ; A. Constantin [France]SAT0022 In Rheumatoid Arthritis, Younger Age at Onset is Associated with a Higher Rate of Remission at 1 Year: Results from a French Cohort of Early Arthritis Patients (Espoir Cohort)
000550 (2013) R. Seror ; S. Legall ; M. Bonnaure-Mallet ; T. Schaeverbeke ; A. Cantagrel [France] ; X. MarietteOP0186 Analysis of Anti Porphyromonas Gingivalis (PG) Antibodies in a Large Cohort of Patients with an Early Arthritis (ESPOIR)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Teeft.i -k "Baseline" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Teeft.i  \
                -Sk "Baseline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Baseline
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021